Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6OV7

CFTR Associated Ligand (CAL) PDZ domain bound to peptide kCAL01

Summary for 6OV7
Entry DOI10.2210/pdb6ov7/pdb
DescriptorGolgi-associated PDZ and coiled-coil motif-containing protein, kCAL01 peptide (3 entities in total)
Functional Keywordspdz domain, inhibitor, complex, peptide binding protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight21144.17
Authors
Gill, N.P.,Madden, D.R. (deposition date: 2019-05-07, release date: 2019-11-20, Last modification date: 2024-10-30)
Primary citationHolt, G.T.,Jou, J.D.,Gill, N.P.,Lowegard, A.U.,Martin, J.W.,Madden, D.R.,Donald, B.R.
Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.
J.Phys.Chem.B, 123:10441-10455, 2019
Cited by
PubMed Abstract: The CFTR-associated ligand PDZ domain (CALP) binds to the cystic fibrosis transmembrane conductance regulator (CFTR) and mediates lysosomal degradation of mature CFTR. Inhibition of this interaction has been explored as a therapeutic avenue for cystic fibrosis. Previously, we reported the ensemble-based computational design of a novel peptide inhibitor of CALP, which resulted in the most binding-efficient inhibitor to date. This inhibitor, kCAL01, was designed using osprey and evinced significant biological activity in cell-based assays. Here, we report a crystal structure of kCAL01 bound to CALP and compare structural features against iCAL36, a previously developed inhibitor of CALP. We compute side-chain energy landscapes for each structure to not only enable approximation of binding thermodynamics but also reveal ensemble features that contribute to the comparatively efficient binding of kCAL01. Finally, we compare the previously reported design ensemble for kCAL01 vs the new crystal structure and show that, despite small differences between the design model and crystal structure, significant biophysical features that enhance inhibitor binding are captured in the design ensemble. This suggests not only that ensemble-based design captured thermodynamically significant features observed , but also that a design eschewing ensembles would miss the kCAL01 sequence entirely.
PubMed: 31697075
DOI: 10.1021/acs.jpcb.9b07278
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.71 Å)
Structure validation

239149

数据于2025-07-23公开中

PDB statisticsPDBj update infoContact PDBjnumon